ERJ Open Research (May 2022)
ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
- Sabina A. Guler,
- Sara Cuevas-Ocaña,
- Mouhamad Nasser,
- Wim A. Wuyts,
- Marlies S. Wijsenbeek,
- Antoine Froidure,
- Elena Bargagli,
- Elisabetta A. Renzoni,
- Marcel Veltkamp,
- Paolo Spagnolo,
- Hilario Nunes,
- Cormac McCarthy,
- Maria Molina-Molina,
- Francesco Bonella,
- Venerino Poletti,
- Michael Kreuter,
- Katerina M. Antoniou,
- Catharina C. Moor
Affiliations
- Sabina A. Guler
- Dept of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- Sara Cuevas-Ocaña
- Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham, UK
- Mouhamad Nasser
- Dept of Respiratory Medicine, National Reference Center for Rare Pulmonary Diseases, Hospices Civils de Lyon, Lyon, France
- Wim A. Wuyts
- Unit for Interstitial Lung Disease, Dept of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium
- Marlies S. Wijsenbeek
- Center for Interstitial Lung Diseases and Sarcoidosis, Dept of Respiratory Medicine, Erasmus MC–University Medical Center Rotterdam, Rotterdam, The Netherlands
- Antoine Froidure
- Service de Pneumologie, Cliniques Universitaires Saint-Luc and Institut de Recherche Expérimentale, UCLouvain, Brussels, Belgium
- Elena Bargagli
- Dept of Medical Sciences, Surgery and Neurosciences, Respiratory Medicine, Siena University, Siena, Italy
- Elisabetta A. Renzoni
- Interstitial Lung Disease Unit, Royal Brompton and Harefield (Guy's and St Thomas’ NHS Foundation Trust), Margaret Turner Warwick Centre for Fibrosing Lung Diseases, NHLI, Imperial College, London, UK
- Marcel Veltkamp
- Interstitial Lung Diseases Centre of Excellence, St Antonius Hospital, Nieuwegein, The Netherlands
- Paolo Spagnolo
- Respiratory Disease Unit, Dept of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy
- Hilario Nunes
- Service de Pneumologie, Centre de Référence des Maladies Pulmonaires Rares, Hôpital Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Nord, Bobigny, France
- Cormac McCarthy
- UCD School of Medicine, Education and Research Centre, St Vincent's University Hospital, Dublin, Ireland
- Maria Molina-Molina
- Dept of Pneumology, Unit of Interstitial Lung Diseases, University Hospital of Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain
- Francesco Bonella
- Center for Interstitial and Rare Lung Diseases, Ruhrlandklinik University Hospital, Duisburg-Essen University, Essen, Germany
- Venerino Poletti
- Dipartimento Malattie dell'Apparato Respiratorio e del Torace Ospedale GB Morgagni-Forlí (FC)/University of Bologna, Bologna, Italy
- Michael Kreuter
- Center for Interstitial and Rare Lung Diseases, and Interdisciplinary Center for Sarcoidosis, Pneumology, Thoraxklinik, University Hospital Heidelberg and German Center for Lung Research, Heidelberg, Germany
- Katerina M. Antoniou
- Laboratory of Molecular and Cellular Pneumonology Laboratory, Dept of Respiratory Medicine, School of Medicine, University of Crete, Crete, Greece
- Catharina C. Moor
- Center for Interstitial Lung Diseases and Sarcoidosis, Dept of Respiratory Medicine, Erasmus MC–University Medical Center Rotterdam, Rotterdam, The Netherlands
- DOI
- https://doi.org/10.1183/23120541.00640-2021
- Journal volume & issue
-
Vol. 8,
no. 2
Abstract
This article provides an overview of scientific highlights in the field of interstitial lung disease (ILD), presented at the virtual European Respiratory Society Congress 2021. A broad range of topics was discussed this year, ranging from translational and genetic aspects to novel innovations with the potential to improve the patient pathway. Early Career Members summarise a selection of interesting findings from different congress sessions, together with the leadership of Assembly 12 – Interstitial Lung Disease.
